Cary Pfeffer
Partner at Third Rock Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Physician who joined Third Rock in 2007 and led partner development efforts, building relationships with biotech and pharma executives and serving as CBO or CEO of portfolio companies at launch, including work on the Agios-Celgene collaboration. Holds a B.A. from Columbia, an M.D. and MBA from the University of Pennsylvania.
Invests in
Biotech
Deals · 3
Rheos MedicinesBoard seat
via Third Rock Ventures · filed Nov 2018
Jounce TherapeuticsBoard seat
via Third Rock Ventures · filed Apr 2015 · $56M raise
Faze MedicinesQuoted
via Third Rock Ventures · filed Dec 2020
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Third Rock Ventures
Network5
Investors connected to Cary in public investor directories — a warm-intro map.